Session slides | Advanced Therapies Week 2026 | Cell & Gene Therapy Conference

Our first San Diego event was a massive success!

Advanced Therapies Week's west coast debut welcomed 1,800 of the industry's foremost experts across clinical science, commercialization, logistics, and regulatory affairs over 4 days.

With over 240 sessions, we understand that you might not have been able to attend every session. We have presentations from all four days of the event available on demand. These slides capture the key takeaways from the experts shaping the future of cell and gene therapy.

*Please be aware that presentation availability is subject to our speaker's approval

Advanced Therapies 2026 presentations

Day 1

Lead through growth - Strategies for funding, talent, and tough decisions

09 Feb 2026 | 01:30 PM - 02:30 PM

From invisible to indispensable: How biotech can build a lean marketing engine

Feb 09 | 02:30 PM - 03:30 PM

Day 2

Driving End-to-End Success in Cell Therapy: Automated, Modular Solutions for Autologous and Allogeneic Workflows

Feb 10 | 08:00 AM - 09:00 AM

From manual to machine: The shifting landscape of cell therapy automation

Feb 10 | 11:30 AM - 11:45 AM

Key Considerations in Preparing for Commercial Approval and Launch

Feb 10 | 12:30 PM - 01:30 PM

Integrating automation in early development

Feb 10 | 02:00 PM - 02:15 PM

Delivering scalable and affordable cell therapy

Feb 10 | 02:15 PM - 02:30 PM

Comparability by design: What worked, what broke, what’s next

Feb 10 | 04:00 PM - 04:40 PM

From days to hours: The closest you can get to real-time sterility testing for cell & gene therapies

Feb 10 | 04:45 PM - 05:00 PM

From Bottleneck to Breakthrough: QC’s Automated Evolution

Feb 10 | 08:00 AM - 09:00 AM

Designing flexible bioseparation strategies for scalable manufacturing

Feb 10 | 11:45 AM - 12:00 PM

Advancing CAR-T Cell Therapy Workflow with Novel Cell Selection and Non-Viral Delivery Methods

Feb 10 | 12:30 PM - 01:00 PM

Rapid implementation of the Accellix Automated Platform in GMP manufacturing

Feb 10 | 01:15 PM - 01:45 PM

Solving cell therapy manufacturing bottlenecks: evaluating closed and automated approaches

Feb 10 | 03:45 PM - 04:45 PM

Collaborating for success: Leveraging platforms solutions and pre-engineering to simplify

Feb 10 | 04:45 PM - 05:00 PM

Advancing CNS gene therapies with manufacturable AAV capsids and an FDA-Integrated regulatory approach

Feb 10 | 11:30 AM - 11:45 AM

Combining startup incubation and GMP manufacturing through public–private partnership

Feb 10 | 11:45 AM - 12:00 PM

Bench-to-bedside development of gene therapy products

Feb 10 | 02:30 PM - 02:45 PM

Collaborative models to accelerate cell and gene therapy translation

Feb 10 | 02:45 PM - 03:00 PM

CDMO partnerships vs in-house manufacturing in advanced therapies

Feb 10 | 02:45 PM - 03:00 PM

Inside the CDMO Landscape: Factors Shaping Advanced Therapies Manufacturing

Feb 10 | 03:30 PM - 03:45 PM

Day 3

Mitigating Cryopreservation Risks with a Single-use Solutions Partner

Feb 11 | 10:00 AM - 10:15 AM

The rise of modular manufacturing: Scalable solutions to accelerate novel therapy development

Feb 11 | 10:15 AM - 10:30 AM

Vitrafy: Elevating cryopreservation from a step to a process

Feb 11 | 10:30 AM - 10:45 AM

AutoCell - Push a Button and Walk Away Cell Therapy Manufacturing

Feb 11 | 11:00 AM - 11:15 AM

Improving purification of viral vectors using Smart Polymer™ affinity ligands

Feb 11 | 11:15 AM - 11:30 AM

Functional restoration in complete SCI: A first-in-class therapy advancing to first-in-human

Feb 11 | 01:00 PM - 01:15 PM

ODC™ (Oligo Dependent Cytotoxicity): Novel class of targeted DNA/RNA therapeutics for cancer, autoimmunity & inflammation

Feb 11 | 01:15 PM - 01:30 PM

TQ Therapeutics: CELLfinity – Hybrid in vivo CGT for scalable patient access

Feb 11 | 01:30 PM - 01:45 PM

Micro Pharmacies

Feb 11 | 01:45 PM - 02:00 PM

Live-cel(tm) Therapy - a Safe and Effective Treatment for Fabry Disease

Feb 11 | 02:15 PM - 02:30 PM

Pythera Therapeutics

Feb 11 | 02:30 PM - 02:45 PM

Zelig Tx: Developing a cure for allergies

Feb 11 | 02:45 PM - 03:00 PM

Reversing Alzheimers via gene therapy and molecular glues

Feb 11 | 03:45 PM - 04:00 PM

Building Scalable Cell Therapy Workflows: Media, Process, and Automation in Action

Feb 11 | 08:00 AM - 09:00 AM

Democratizing Gene-Modified Cell Therapy Through Lipid-Based Transfection

Feb 11 | 10:30 AM - 10:45 AM

Novel, redosable in vivo CAR platform for reprogramming multiple immune cell types against solid tumors

Feb 11 | 10:45 AM - 11:00 AM

Applying 20 Years of Cell Therapy Point-of-Care Manufacturing Lessons to Automated CD19 CAR-T Production

Feb 11 | 11:00 AM - 11:15 AM

Spotlight: From bottleneck to breakthrough: Scaling viral vectors without breaking the bank

Feb 11 | 11:15 AM - 11:30 AM

Next gen tools for cell therapy manufacturing: Addressing key reagent challenges

Feb 11 | 02:00 PM - 02:15 PM

NGS-Driven quality: Redefining biosafety and release strategies in advanced therapy manufacturing

Feb 11 | 02:15 PM - 02:30 PM

The Mygotic Process -The next advancement in the production of autologous totipotent cells from somatic cells

Feb 11 | 02:45 PM - 03:00 PM

Digital Integration in Cell Therapy: Enabling Scalable MES and Accelerating Manufacturing

Feb 11 | 08:00 AM - 08:30 AM

Allogeneic therapies as a pathway to long-term scalability

Feb 11 | 02:00 PM - 02:15 PM

Standardizing material management in cell and gene therapy: A consensus framework for quality, risk, and regulatory alignment

Feb 11 | 04:00 PM - 04:15 PM

The key to accessibility and ROI: Microbubbles unlock speed, quality, and cost efficiency in CGT manufacturing

Feb 11 | 11:15 AM - 11:30 AM

Beyond the data on international day of women and girls in science

Feb 11 | 11:15 AM - 12:00 PM

Day 4

SynCav1 Gene Therapy for CNS Disorders

Feb 12 | 11:00 AM - 11:15 AM

Challenges for CNS directed gene therapies for rare neurogenetic disease

Feb 12 | 11:15 AM - 11:30 AM

Curative cell therapies for type 1 diabetes: how close are we? 

Feb 12 | 11:30 AM - 11:45 AM

Biomarkers and Companion diagnostics in CGT Trials: Enabling precision and predictability

Feb 12 | 11:00 AM - 11:15 AM

“I get SO MUCH information at this show that sets me up for the year. It’s what I love about it. To me, ATW is the start of the year.”

Principal, WMC
“The Super Bowl of Advanced Cell Therapy conferences.”

Patient & Author
“Advanced Therapies Week is one of the best partnering conferences around… they really focus on connections.”

Global Commercial Director, ScaleReady
“Why Advanced Therapies Week is fantastic is all the tech developers and manufacturers are here in one place, with one idea in mind, and that’s to advance the field. Coalescence like this is absolutely key!”

VP, Cellular Origins